Moderna’s CEO has FINALLY admitted the truth about COVID and the vaccines his company offers – revealing we’ve been seriously misled about the virus.
The CEO Stephane Bancel spoke with Yahoo Finance’s Anjalee Khemlani at the 2022 Yahoo Finance All Markets Summit.
During that discussion Bancel confessed that COVID-19 is, in reality, very similar to the seasonal flu. Bancel also suggested that only people above the age of 50 and others in more vulnerable categories should even consider taking a booster shot.
Khemlani asked, “Is the COVID vaccine going to be an annual COVID booster for a very long time to come or maybe for the rest of our lives? And how do you merge that with the fact that there is already low uptake of this new variant booster?
Bancel responded, “… I think it’s going to be very similar to flu, where it’s going to be people at high risk, people above 50 years of age, people with comorbidity, people with cancer and other conditions… And that’s really important to think about. And if you look at it around the world, that is 1.5 billion people. So it’s a lot of people that’s going to need an annual booster and people that are younger going to have to decide for themselves what they want to do.”
Bancel’s admission reveals a rather telling truth about what COVID-19 really is, likening it to the seasonal flu.
It’s also quite the reversal for the Moderna CEO who just a year ago insisted that even younger people will have to get vaccine booster shots at least once every year for ever if normality is ever to return.
The mainstream efforts to fear-monger people regarding the virus have largely worn off and as a result, the number of booster shots administered has tanked with it.
Still, the most recently FDA approved booster shot was done so without any human testing and could prove to be even riskier than its predecessors.
Even Dr. Paul Offit, a top vaccine expert and FDA adviser has warned that there is insufficient evidence to recommend the new booster shot for healthy young adults and said it could carry deadly risks.
Dr. Offit said, “When you’re asking people to get a vaccine, I think there has to be clear evidence of benefit. And we’re not going to have clinical studies, obviously, before this launches, but you’d like to have at least human data on people getting this vaccine. You see a clear and dramatic increase in neutralizing antibiotics, and then at least you have a correlate of protection against BA4, BA5. Because if you don’t have that, if there’s not clear evidence of benefit, then it’s not fair [to ask people to take a risk]. The benefits should be clear.”